Great Lakes NeuroTechnologies

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Great Lakes NeuroTechnologies sits in the top decile of US sponsors by registered trial count (#842 of 15,742 sponsors by registered trial count).

17 total trials none currently recruiting 17 completed top decile by trial count

Great Lakes NeuroTechnologies: 17 sponsored US clinical trials, none currently recruiting.

Great Lakes NeuroTechnologies sponsors 17 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 17 completed. The most-studied condition in this pipeline is Parkinson's Disease, with 2 trials.

Top-decile sponsor footprint

Great Lakes NeuroTechnologies ranks in the top decile of sponsors by registered trial count (#842 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

A 90/100

17 of 17 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

17 total, page 1 of 1

COMPLETED

DiSCERN: Advanced PD Therapy Candidacy and Evaluation System

NCT05351580
COMPLETED

Objective Quality of Life Detection Validation

NCT04121793
COMPLETED NA

Kinesia 360 Parkinson's Monitoring Study

NCT02657655
COMPLETED

BradyXplore Phase II: Bradykinesia Feature Extraction System

NCT02358876
COMPLETED

Ambulatory Parkinson's Disease Dyskinesia Monitor for Drug Therapy Titration

NCT02125825
COMPLETED NA

Automated Telehealth Diagnostics for Remote Parkinson Monitoring

NCT02152319
COMPLETED NA

ParkinStim: Transcranial Direct Current Stimulation for Parkinson's Disease

NCT02125383
COMPLETED

MyoSense- Automated Muscle Hypertonicity Classification System

NCT02076581
COMPLETED

Parkinstep: Automated PD Gait and Balance Assessment for Optimizing DBS

NCT02080572
COMPLETED NA

Pilot Study for Automated Deep Brain Stimulation Programming

NCT02046863
COMPLETED NA

Continuous Tremor Assessment During Daily Activities

NCT01978080
COMPLETED NA

Kinesia HomeView - Home Diary Comparison

NCT01920425
COMPLETED

Adaptive Portable Essential Tremor Monitor

NCT01602042
COMPLETED

Movement Disorder Quantification Algorithm Development

NCT01534650
COMPLETED

Automated Parkinson's Disease (PD) Motor Symptom Assessment for Deep Brain Stimulation (DBS) Programming

NCT01429220
COMPLETED

Capturing Parkinson's Disease Medication Side Effects During Daily Activities

NCT01429207
COMPLETED

Tele-diagnostics for Remote Parkinson's Monitoring

NCT01356056

Therapeutic Areas

Parkinson's Disease 2
Bradykinesia 1
Tremor 1

How the Great Lakes NeuroTechnologies archive is shaped

17 indexed studies, none listed as recruiting (0% open); 17 completed (100%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Parkinson's Disease (2 trials), 2 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Great Lakes NeuroTechnologies: archived-pipeline peers nationwide

Peers matched on 17 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Great Lakes NeuroTechnologies sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05101520 0%5%10%15%20%25% Total trials Recruiting share Great Lakes NeuroTechnologiesAchieve Life SciencesBioDelivery Sciences InternationalChugai PharmaceuticalConvaTec10xBio22nd Century Group23andMe3-C Institute for Social Development
Great Lakes NeuroTechnologies sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Great Lakes NeuroTechnologies sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 17 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Great Lakes NeuroTechnologies page

17 registered trials is a research-attention snapshot, not an endorsement of Great Lakes NeuroTechnologies or any single study.

  • None of Great Lakes NeuroTechnologies's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Parkinson's Disease is the condition Great Lakes NeuroTechnologies studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Parkinson's Disease trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Great Lakes NeuroTechnologies pipeline card: 17 registered trials from official public datasets.Report a data error.